Apyx Medical (APYX) Stock: Buy, Sell, or Hold?
APYX - Apyx Medical Corporation Common Stock
$2.90
0.01 (0.35%)
â˛
5d:
-5.23%
30d:
-3.01%
90d:
-37.63%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When APYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: APYX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: APYX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: APYX is currently trading at $2.90, which is considered slightly low relative to its 30-day fair value range of $2.84 to $3.52.
Technical Outlook: Technically, APYX is in a downtrend. Immediate support is located at $2.79, while resistance sits at $3.22.
Market Sentiment: APYX scores 11/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.60 (+127.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APYX is in a downtrend. Immediate support is located at $2.79, while resistance sits at $3.22.
Market Sentiment: APYX scores 11/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.60 (+127.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.84 -
$3.52
Company Quality Score
38/100
(SELL)
Options IV Signal
39th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 39th percentile)
- BEARISH: Weak technical setup (11/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 127.6% below Wall St target ($6.60)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.84 -
$3.52
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
Âą$0.45
(15.5%)
Support & Resistance Levels
Support Level
$2.79
Resistance Level
$3.22
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.24
Wall Street Target
$6.60
(+127.6%)
Revenue Growth (YoY)
22.1%
Profit Margin
-14.8%
Share & Embed Analysis
Last updated: September 13, 2026 10:07 AM ET
Data refreshes hourly during market hours. Next update: 11:07 AM
Data refreshes hourly during market hours. Next update: 11:07 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$62 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$376 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
